Results 261 to 270 of about 10,947,715 (346)
No allergy, but mast cells are involved: MRGPRX2 in chronic inflammatory skin diseases. [PDF]
Metz M.
europepmc +1 more source
Surgical Implantation of Hodgkinʼs Disease of the Stomach to the Skin of the Abdominal Wall
F. C. Jackson+2 more
openalex +2 more sources
Semiconducting Polymer Nanoparticles as Multimodal Agents for Optical and Magnetic Resonance Imaging
Semiconducting polymer nanoparticles (SPNs) exhibit many advantageous optical and biological properties. Multimodal SPN‐based contrast agents that integrate several imaging modalities yield a wealth of information through the use of different imaging mechanisms.
Faysal A. Farah+3 more
wiley +1 more source
Macrophages in inflammatory skin diseases and skin tumors. [PDF]
Liu SH, Zhang J, Zuo YG.
europepmc +1 more source
This review highlights recent advances in microfluidic technologies for modeling human aging and age‐related diseases. It explores how organ‐on‐chip platforms improve physiological relevance, enable rejuvenation strategies, facilitate drug screening, detect senescent cells, and identify biomarkers.
Limor Zwi‐Dantsis+5 more
wiley +1 more source
Prevalence of skin diseases in women with endometriosis: a cross-sectional study. [PDF]
Sakiyama PH+5 more
europepmc +1 more source
Advanced Oral Delivery Systems for Nutraceuticals
Emerging delivery technologies are explored to overcome barriers to oral nutraceutical absorption. Traditional carriers are compared with novel platforms including biodegradable polymers, MOFs, MPNs, and 3D printing. These systems enhance bioavailability, control release, and enable personalized nutrition.
Xin Yang+4 more
wiley +1 more source
Plant-Based Foods for Chronic Skin Diseases: A Focus on the Mediterranean Diet. [PDF]
Annunziata G+7 more
europepmc +1 more source
Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis
This review highlights the potential of organ‐on‐a‐chip systems for studying comorbidities, using chronic kidney disease (CKD) and osteoarthritis (OA) as examples. It summarizes recent advances in kidney‐on‐a‐chip and joint‐on‐a‐chip models and discusses their current and potential application in investigating CKD, OA, and CKD‐OA comorbidity, aiming to
Mingying Han+7 more
wiley +1 more source
Lipid Abundance and Metabolism Aberrations in Skin Diseases. [PDF]
Nowowiejska J.
europepmc +1 more source